Vasomotor symptoms (VMS) and endothelial function: A randomised placebo-controlled trial of oral micronised Progesterone (Prometrium ®)

Prior JC, 2012

Prior JC

2012

Abstract

No abstract available for this article.

Topics

Reproductive Endocrinology > Progesterone > Supplementation Perimenopause/Menopause > Symptoms > Vasomotor Perimenopause/Menopause > HRT > Alternatives

oral micronized progesterone trial, prometrium hot flashes, progesterone vasomotor symptoms, bioidentical progesterone menopause, progesterone endothelial function, natural progesterone perimenopause, micronized progesterone rct, hot flashes progesterone treatment, vascular health progesterone therapy, prometrium clinical trial results

Cite this article

Prior, J. C. (2012). *Vasomotor symptoms (VMS) and endothelial function: A randomised placebo-controlled trial of oral micronised Progesterone (Prometrium ®)*. https://doi.org/10.1186/isrctn16052610

Vasomotor symptoms (VMS) and endothelial function: A randomised placebo-controlled trial of oral micronised Progesterone (Prometrium ®)

Abstract

Topics

Cite this article

Related articles

Oral micronized progesterone for perimenopausal night sweats and hot flushes a Phase III Canada-wide randomized placebo-controlled 4 month trial

Effects of progesterone therapy on serum sclerostin levels in healthy menopausal women: a 3-month randomized, placebo-controlled clinical trial

Progesterone for treatment of symptomatic menopausal women

Progesterone for hot flush and night sweat treatment--effectiveness for severe vasomotor symptoms and lack of withdrawal rebound

Hot flushes and night sweats differ in associations with cardiovascular markers in healthy early postmenopausal women